未登录

P

Patrick Peterson

Eli Lilly

H指数:11

被引数:523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

CLINICAL CANCER RESEARCH

IF10.2

2023-06-292

OAAI

Results of an open-label, phase Ia/Ib study of olaratumab plus pembrolizumab in patients with unresectable, locally advanced or metastatic soft tissue sarcoma

ANNALS OF ONCOLOGY

IF65.4

2021-12-012

OA

Results of a randomized, double-blind, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel ± olaratumab in treatment-naive patients with unresectable metastatic pancreatic cancer

ANNALS OF ONCOLOGY

IF65.4

2021-09-011

OAAI

Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer

在晚期乳腺癌患者的III期临床试验中，患者报告的疼痛和其他生活质量领域作为生存的预后因素

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2016-03-2530

OAAI